TY - JOUR AU - Parkin, D. M. AU - Bray, F. PY - 2006 DA - 2006// TI - Chapter 2: The burden of HPV-related cancers JO - Vaccine VL - 24 UR - https://doi.org/10.1016/j.vaccine.2006.05.111 DO - 10.1016/j.vaccine.2006.05.111 ID - Parkin2006 ER - TY - JOUR AU - Walboomers, J. M. AU - Jacobs, M. V. AU - Manos, M. M. AU - Bosch, F. X. AU - Kummer, J. A. AU - Shah, K. V. PY - 1999 DA - 1999// TI - Human papillomavirus is a necessary cause of invasive cervical cancer worldwide JO - J. Pathol. VL - 189 UR - https://doi.org/3.0.CO;2-F DO - 3.0.CO;2-F ID - Walboomers1999 ER - TY - JOUR AU - Munoz, N. AU - Bosch, F. X. AU - Sanjose, S. AU - Herrero, R. AU - Castellsague, X. AU - Shah, K. V. PY - 2003 DA - 2003// TI - Epidemiologic classification of human papillomavirus types associated with cervical cancer JO - N. Engl. J. Med. VL - 348 UR - https://doi.org/10.1056/NEJMoa021641 DO - 10.1056/NEJMoa021641 ID - Munoz2003 ER - TY - JOUR AU - Munoz, N. AU - Bosch, F. X. AU - Castellsague, X. AU - Diaz, M. AU - Sanjose, S. AU - Hammouda, D. PY - 2004 DA - 2004// TI - Against which human papillomavirus types shall we vaccinate and screen? The international perspective JO - Int. J. Cancer VL - 111 UR - https://doi.org/10.1002/ijc.20244 DO - 10.1002/ijc.20244 ID - Munoz2004 ER - TY - JOUR AU - ZurHausen, H. PY - 2002 DA - 2002// TI - Papillomaviruses and cancer: from basic studies to clinical application JO - Nature Rev Cancer VL - 2 UR - https://doi.org/10.1038/nrc798 DO - 10.1038/nrc798 ID - ZurHausen2002 ER - TY - JOUR AU - Munger, K. AU - Baldwin, A. AU - Edwards, K. M. AU - Hayakawa, H. AU - Nguyen, C. L. AU - Owens, M. PY - 2004 DA - 2004// TI - Mechanisms of human papillomavirus-induced oncogenesis JO - J. Virol. VL - 78 UR - https://doi.org/10.1128/JVI.78.21.11451-11460.2004 DO - 10.1128/JVI.78.21.11451-11460.2004 ID - Munger2004 ER - TY - JOUR AU - Doorbar, J. PY - 2005 DA - 2005// TI - The papillomavirus life cycle JO - J. Clin. Virol. VL - 32 UR - https://doi.org/10.1016/j.jcv.2004.12.006 DO - 10.1016/j.jcv.2004.12.006 ID - Doorbar2005 ER - TY - JOUR AU - Doorbar, J. AU - Ely, S. AU - Sterling, J. AU - McLean, C. AU - Crawford, L. PY - 1991 DA - 1991// TI - Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network JO - Nature VL - 352 UR - https://doi.org/10.1038/352824a0 DO - 10.1038/352824a0 ID - Doorbar1991 ER - TY - JOUR AU - Wang, J. W. AU - Hung, C. F. AU - Huh, W. K. AU - Trimble, C. L. AU - Roden, R. B. PY - 2015 DA - 2015// TI - Immunoprevention of human papillomavirus-associated malignancies JO - Cancer Prevent Res VL - 8 UR - https://doi.org/10.1158/1940-6207.CAPR-14-0311 DO - 10.1158/1940-6207.CAPR-14-0311 ID - Wang2015 ER - TY - JOUR AU - Paavonen, J. AU - Naud, P. AU - Salmeron, J. AU - Wheeler, C. M. AU - Chow, S. N. AU - Apter, D. PY - 2009 DA - 2009// TI - Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)61248-4 DO - 10.1016/S0140-6736(09)61248-4 ID - Paavonen2009 ER - TY - JOUR AU - Wheeler, C. M. AU - Castellsague, X. AU - Garland, S. M. AU - Szarewski, A. AU - Paavonen, J. AU - Naud, P. PY - 2012 DA - 2012// TI - Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(11)70287-X DO - 10.1016/S1470-2045(11)70287-X ID - Wheeler2012 ER - TY - JOUR AU - Garland, S. M. AU - Hernandez-Avila, M. AU - Wheeler, C. M. AU - Perez, G. AU - Harper, D. M. AU - Leodolter, S. PY - 2007 DA - 2007// TI - Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases JO - N. Engl. J. Med. VL - 356 UR - https://doi.org/10.1056/NEJMoa061760 DO - 10.1056/NEJMoa061760 ID - Garland2007 ER - TY - JOUR AU - Dillner, J. AU - Kjaer, S. K. AU - Wheeler, C. M. AU - Sigurdsson, K. AU - Iversen, O. E. AU - Hernandez-Avila, M. PY - 2010 DA - 2010// TI - Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial JO - BMJ VL - 341 UR - https://doi.org/10.1136/bmj.c5128 DO - 10.1136/bmj.c5128 ID - Dillner2010 ER - TY - JOUR AU - Roden, R. B. AU - Greenstone, H. L. AU - Kirnbauer, R. AU - Booy, F. P. AU - Jessie, J. AU - Lowy, D. R. PY - 1996 DA - 1996// TI - In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype JO - J. Virol. VL - 70 ID - Roden1996 ER - TY - JOUR AU - Roden, R. B. AU - Hubbert, N. L. AU - Kirnbauer, R. AU - Christensen, N. D. AU - Lowy, D. R. AU - Schiller, J. T. PY - 1996 DA - 1996// TI - Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition JO - J. Virol. VL - 70 ID - Roden1996 ER - TY - JOUR AU - Jemal, A. AU - Simard, E. P. AU - Dorell, C. AU - Noone, A. M. AU - Markowitz, L. E. AU - Kohler, B. PY - 2013 DA - 2013// TI - Annual Report to the Nation on the Status of Cancer, 1975–2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels JO - J. Natl. Cancer Inst. VL - 105 UR - https://doi.org/10.1093/jnci/djs491 DO - 10.1093/jnci/djs491 ID - Jemal2013 ER - TY - JOUR AU - Roden, R. B. AU - Yutzy, W. H. AU - Fallon, R. AU - Inglis, S. AU - Lowy, D. R. AU - Schiller, J. T. PY - 2000 DA - 2000// TI - Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes JO - Virology VL - 270 UR - https://doi.org/10.1006/viro.2000.0272 DO - 10.1006/viro.2000.0272 ID - Roden2000 ER - TY - JOUR AU - Richards, R. M. AU - Lowy, D. R. AU - Schiller, J. T. AU - Day, P. M. PY - 2006 DA - 2006// TI - Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection JO - Proc. Natl. Acad. Sci. U. S. A. VL - 103 UR - https://doi.org/10.1073/pnas.0508815103 DO - 10.1073/pnas.0508815103 ID - Richards2006 ER - TY - JOUR AU - Bronnimann, M. P. AU - Chapman, J. A. AU - Park, C. K. AU - Campos, S. K. PY - 2013 DA - 2013// TI - A Transmembrane Domain and GxxxG Motifs Within L2 are Essential for Papillomavirus Infection JO - J. Virol. VL - 87 UR - https://doi.org/10.1128/JVI.01539-12 DO - 10.1128/JVI.01539-12 ID - Bronnimann2013 ER - TY - JOUR AU - Gambhira, R. AU - Karanam, B. AU - Jagu, S. AU - Roberts, J. N. AU - Buck, C. B. AU - Bossis, I. PY - 2007 DA - 2007// TI - A protective and broadly cross-neutralizing epitope of Human Papillomavirus L2 JO - J. Virol. VL - 81 UR - https://doi.org/10.1128/JVI.00936-07 DO - 10.1128/JVI.00936-07 ID - Gambhira2007 ER - TY - JOUR AU - Rubio, I. AU - Seitz, H. AU - Canali, E. AU - Sehr, P. AU - Bolchi, A. AU - Tommasino, M. PY - 2011 DA - 2011// TI - The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies JO - Virology VL - 409 UR - https://doi.org/10.1016/j.virol.2010.10.017 DO - 10.1016/j.virol.2010.10.017 ID - Rubio2011 ER - TY - JOUR AU - Kondo, K. AU - Ishii, Y. AU - Ochi, H. AU - Matsumoto, T. AU - Yoshikawa, H. AU - Kanda, T. PY - 2007 DA - 2007// TI - Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region JO - Virology VL - 358 UR - https://doi.org/10.1016/j.virol.2006.08.037 DO - 10.1016/j.virol.2006.08.037 ID - Kondo2007 ER - TY - JOUR AU - Gambhira, R. AU - Jagu, S. AU - Karanam, B. AU - Gravitt, P. E. AU - Culp, T. D. AU - Christensen, N. D. PY - 2007 DA - 2007// TI - Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N-terminus of HPV16 minor capsid antigen L2 JO - J. Virol. VL - 81 UR - https://doi.org/10.1128/JVI.00936-07 DO - 10.1128/JVI.00936-07 ID - Gambhira2007 ER - TY - JOUR AU - Wang, J. W. AU - Roden, R. B. PY - 2013 DA - 2013// TI - Virus-like particles for the prevention of human papillomavirus-associated malignancies JO - Expert Rev Vacc VL - 12 UR - https://doi.org/10.1586/erv.12.151 DO - 10.1586/erv.12.151 ID - Wang2013 ER - TY - JOUR AU - Rux, J. J. AU - Kuser, P. R. AU - Burnett, R. M. PY - 2003 DA - 2003// TI - Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods JO - J. Virol. VL - 77 UR - https://doi.org/10.1128/JVI.77.17.9553-9566.2003 DO - 10.1128/JVI.77.17.9553-9566.2003 ID - Rux2003 ER - TY - JOUR AU - Rux, J. J. AU - Burnett, R. M. PY - 2004 DA - 2004// TI - Adenovirus structure JO - Hum. Gene Ther. VL - 15 UR - https://doi.org/10.1089/hum.2004.15.1167 DO - 10.1089/hum.2004.15.1167 ID - Rux2004 ER - TY - JOUR AU - Sharma, A. AU - Krause, A. AU - Xu, Y. AU - Sung, B. AU - Wu, W. AU - Worgall, S. PY - 2013 DA - 2013// TI - Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0056996 DO - 10.1371/journal.pone.0056996 ID - Sharma2013 ER - TY - JOUR AU - Farrow, A. L. AU - Rachakonda, G. AU - Gu, L. AU - Krendelchtchikova, V. AU - Nde, P. N. AU - Pratap, S. PY - 2014 DA - 2014// TI - Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection JO - PLoS Negl. Trop. Dis. VL - 8 UR - https://doi.org/10.1371/journal.pntd.0003089 DO - 10.1371/journal.pntd.0003089 ID - Farrow2014 ER - TY - JOUR AU - Palma, C. AU - Overstreet, M. G. AU - Guedon, J. M. AU - Hoiczyk, E. AU - Ward, C. AU - Karen, K. A. PY - 2011 DA - 2011// TI - Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice JO - Vaccine VL - 29 UR - https://doi.org/10.1016/j.vaccine.2010.12.040 DO - 10.1016/j.vaccine.2010.12.040 ID - Palma2011 ER - TY - JOUR AU - Top, F. H. AU - Buescher, E. L. AU - Bancroft, W. H. AU - Russell, P. K. PY - 1971 DA - 1971// TI - Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7 JO - J Infect Dis VL - 124 UR - https://doi.org/10.1093/infdis/124.2.155 DO - 10.1093/infdis/124.2.155 ID - Top1971 ER - TY - JOUR AU - Top, F. H. AU - Grossman, R. A. AU - Bartelloni, P. J. AU - Segal, H. E. AU - Dudding, B. A. AU - Russell, P. K. PY - 1971 DA - 1971// TI - Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans JO - J Infect Dis VL - 124 UR - https://doi.org/10.1093/infdis/124.2.148 DO - 10.1093/infdis/124.2.148 ID - Top1971 ER - TY - JOUR AU - Crompton, J. AU - Toogood, C. I. AU - Wallis, N. AU - Hay, R. T. PY - 1994 DA - 1994// TI - Expression of a foreign epitope on the surface of the adenovirus hexon JO - J Gen Virol VL - 75 UR - https://doi.org/10.1099/0022-1317-75-1-133 DO - 10.1099/0022-1317-75-1-133 ID - Crompton1994 ER - TY - JOUR AU - Pastrana, D. V. AU - Gambhira, R. AU - Buck, C. B. AU - Pang, Y. Y. AU - Thompson, C. D. AU - Culp, T. D. PY - 2005 DA - 2005// TI - Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2 JO - Virology VL - 337 UR - https://doi.org/10.1016/j.virol.2005.04.011 DO - 10.1016/j.virol.2005.04.011 ID - Pastrana2005 ER - TY - JOUR AU - Deal, C. AU - Pekosz, A. AU - Ketner, G. PY - 2013 DA - 2013// TI - Prospects for oral replicating adenovirus-vectored vaccines JO - Vaccine VL - 31 UR - https://doi.org/10.1016/j.vaccine.2013.05.016 DO - 10.1016/j.vaccine.2013.05.016 ID - Deal2013 ER - TY - JOUR AU - Campo, M. S. AU - O'Neil, B. W. AU - Grindlay, G. J. AU - Curtis, F. AU - Knowles, G. AU - Chandrachud, L. PY - 1997 DA - 1997// TI - A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease JO - Virology VL - 234 UR - https://doi.org/10.1006/viro.1997.8649 DO - 10.1006/viro.1997.8649 ID - Campo1997 ER - TY - JOUR AU - Lin, Y. L. AU - Borenstein, L. A. AU - Selvakumar, R. AU - Ahmed, R. AU - Wettstein, F. O. PY - 1992 DA - 1992// TI - Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus JO - Virology VL - 187 UR - https://doi.org/10.1016/0042-6822(92)90463-Y DO - 10.1016/0042-6822(92)90463-Y ID - Lin1992 ER - TY - JOUR AU - Roden, R. B. AU - Yutzy, W. I. AU - Fallon, R. AU - Inglis, S. AU - Lowy, D. R. AU - Schiller, J. T. PY - 2000 DA - 2000// TI - Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes JO - Virology VL - 270 UR - https://doi.org/10.1006/viro.2000.0272 DO - 10.1006/viro.2000.0272 ID - Roden2000 ER - TY - JOUR AU - Chackerian, B. AU - Lenz, P. AU - Lowy, D. R. AU - Schiller, J. T. PY - 2002 DA - 2002// TI - Determinants of autoantibody induction by conjugated papillomavirus virus-like particles JO - J. Immunol. VL - 169 UR - https://doi.org/10.4049/jimmunol.169.11.6120 DO - 10.4049/jimmunol.169.11.6120 ID - Chackerian2002 ER - TY - JOUR AU - Palmer, K. E. AU - Benko, A. AU - Doucette, S. A. AU - Cameron, T. I. AU - Foster, T. AU - Hanley, K. M. PY - 2006 DA - 2006// TI - Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes JO - Vaccine VL - 24 UR - https://doi.org/10.1016/j.vaccine.2006.04.058 DO - 10.1016/j.vaccine.2006.04.058 ID - Palmer2006 ER - TY - JOUR AU - Worgall, S. AU - Krause, A. AU - Qiu, J. AU - Joh, J. AU - Hackett, N. R. AU - Crystal, R. G. PY - 2007 DA - 2007// TI - Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF JO - J. Virol. VL - 81 UR - https://doi.org/10.1128/JVI.01246-07 DO - 10.1128/JVI.01246-07 ID - Worgall2007 ER - TY - JOUR AU - McConnell, M. J. AU - Danthinne, X. AU - Imperiale, M. J. PY - 2006 DA - 2006// TI - Characterization of a permissive epitope insertion site in adenovirus hexon JO - J. Virol. VL - 80 UR - https://doi.org/10.1128/JVI.00256-06 DO - 10.1128/JVI.00256-06 ID - McConnell2006 ER - TY - JOUR AU - Matthews, Q. L. AU - Yang, P. AU - Wu, Q. AU - Belousova, N. AU - Rivera, A. A. AU - Stoff-Khalili, M. A. PY - 2008 DA - 2008// TI - Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach JO - Virol. J. VL - 5 UR - https://doi.org/10.1186/1743-422X-5-98 DO - 10.1186/1743-422X-5-98 ID - Matthews2008 ER - TY - JOUR AU - Krause, A. AU - Joh, J. H. AU - Hackett, N. R. AU - Roelvink, P. W. AU - Bruder, J. T. AU - Wickham, T. J. PY - 2006 DA - 2006// TI - Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity JO - J. Virol. VL - 80 UR - https://doi.org/10.1128/JVI.02667-05 DO - 10.1128/JVI.02667-05 ID - Krause2006 ER - TY - JOUR AU - Nociari, M. AU - Ocheretina, O. AU - Schoggins, J. W. AU - Falck-Pedersen, E. PY - 2007 DA - 2007// TI - Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator JO - J. Virol. VL - 81 UR - https://doi.org/10.1128/JVI.02685-06 DO - 10.1128/JVI.02685-06 ID - Nociari2007 ER - TY - JOUR AU - Gutekunst, R. R. AU - White, R. J. AU - Edmondson, W. P. AU - Chanock, R. M. PY - 1967 DA - 1967// TI - Immunization with live type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection JO - Am. J. Epidemiol. VL - 86 ID - Gutekunst1967 ER - TY - JOUR AU - Alphs, H. H. AU - Gambhira, R. AU - Karanam, B. AU - Roberts, J. N. AU - Jagu, S. AU - Schiller, J. T. PY - 2008 DA - 2008// TI - Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2 JO - Proc. Natl. Acad. Sci. U. S. A. VL - 105 UR - https://doi.org/10.1073/pnas.0800868105 DO - 10.1073/pnas.0800868105 ID - Alphs2008 ER - TY - JOUR AU - Schellenbacher, C. AU - Roden, R. AU - Kirnbauer, R. PY - 2009 DA - 2009// TI - Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines JO - J. Virol. VL - 83 UR - https://doi.org/10.1128/JVI.01088-09 DO - 10.1128/JVI.01088-09 ID - Schellenbacher2009 ER - TY - JOUR AU - Schellenbacher, C. AU - Kwak, K. AU - Fink, D. AU - Shafti-Keramat, S. AU - Huber, B. AU - Jindra, C. PY - 2013 DA - 2013// TI - Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses JO - J Investig Dermatol ID - Schellenbacher2013 ER - TY - JOUR AU - Tumban, E. AU - Peabody, J. AU - Peabody, D. S. AU - Chackerian, B. PY - 2013 DA - 2013// TI - A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants JO - Vaccine VL - 31 UR - https://doi.org/10.1016/j.vaccine.2013.07.052 DO - 10.1016/j.vaccine.2013.07.052 ID - Tumban2013 ER - TY - JOUR AU - Nieto, K. AU - Weghofer, M. AU - Sehr, P. AU - Ritter, M. AU - Sedlmeier, S. AU - Karanam, B. PY - 2012 DA - 2012// TI - Development of AAVLP(HPV16/31 L2) particles as broadly protective HPV vaccine candidate JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0039741 DO - 10.1371/journal.pone.0039741 ID - Nieto2012 ER - TY - JOUR AU - Jagu, S. AU - Kwak, K. AU - Schiller, J. T. AU - Lowy, D. R. AU - Kleanthous, H. AU - Kalnin, K. PY - 2013 DA - 2013// TI - Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine JO - J. Virol. VL - 87 UR - https://doi.org/10.1128/JVI.03218-12 DO - 10.1128/JVI.03218-12 ID - Jagu2013 ER - TY - JOUR AU - Smaill, F. AU - Jeyanathan, M. AU - Smieja, M. AU - Medina, M. F. AU - Thanthrige-Don, N. AU - Zganiacz, A. PY - 2013 DA - 2013// TI - A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity JO - Sci. Transl. Med. VL - 5 UR - https://doi.org/10.1126/scitranslmed.3006843 DO - 10.1126/scitranslmed.3006843 ID - Smaill2013 ER - TY - JOUR AU - Thomason, L. C. AU - Sawitzke, J. A. AU - Li, X. AU - Costantino, N. AU - Court, D. L. PY - 2014 DA - 2014// TI - Recombineering: genetic engineering in bacteria using homologous recombination JO - Curr Protoc Mol Biol VL - 106 UR - https://doi.org/10.1002/0471142727.mb0116s106 DO - 10.1002/0471142727.mb0116s106 ID - Thomason2014 ER - TY - JOUR AU - Graham, F. L. AU - Eb, A. J. PY - 1973 DA - 1973// TI - A new technique for the assay of infectivity of human adenovirus 5 DNA JO - Virology VL - 52 UR - https://doi.org/10.1016/0042-6822(73)90341-3 DO - 10.1016/0042-6822(73)90341-3 ID - Graham1973 ER - TY - JOUR AU - Karen, K. A. AU - Deal, C. AU - Adams, R. J. AU - Nielsen, C. AU - Ward, C. AU - Espinosa, D. A. PY - 2015 DA - 2015// TI - A replicating adenovirus capsid display recombinant elicits antibodies against Plasmodium falciparum sporozoites in Aotus nancymaae monkeys JO - Infect. Immun. VL - 83 UR - https://doi.org/10.1128/IAI.02626-14 DO - 10.1128/IAI.02626-14 ID - Karen2015 ER - TY - JOUR AU - Berg, M. G. AU - Adams, R. J. AU - Gambhira, R. AU - Siracusa, M. C. AU - Scott, A. L. AU - Roden, R. B. PY - 2014 DA - 2014// TI - Immune responses in macaques to a prototype recombinant adenovirus live oral human papillomavirus 16 vaccine JO - Clin Vaccine Immunol VL - 21 UR - https://doi.org/10.1128/CVI.00197-14 DO - 10.1128/CVI.00197-14 ID - Berg2014 ER - TY - JOUR AU - Roberts, J. N. AU - Buck, C. B. AU - Thompson, C. D. AU - Kines, R. AU - Bernardo, M. AU - Choyke, P. L. PY - 2007 DA - 2007// TI - Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan JO - Nat. Med. VL - 13 UR - https://doi.org/10.1038/nm1598 DO - 10.1038/nm1598 ID - Roberts2007 ER - TY - JOUR AU - Wang, J. W. AU - Jagu, S. AU - Wang, C. AU - Kitchener, H. C. AU - Daayana, S. AU - Stern, P. L. PY - 2014 DA - 2014// TI - Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV Pseudovirions JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0101576 DO - 10.1371/journal.pone.0101576 ID - Wang2014 ER - TY - JOUR AU - Gambhira, R. AU - Karanam, B. AU - Jagu, S. AU - Roberts, J. N. AU - Buck, C. B. AU - Bossis, I. PY - 2007 DA - 2007// TI - A protective and broadly cross-neutralizing epitope of human papillomavirus L2 JO - J. Virol. VL - 81 UR - https://doi.org/10.1128/JVI.00936-07 DO - 10.1128/JVI.00936-07 ID - Gambhira2007 ER - TY - JOUR AU - Handisurya, A. AU - Day, P. M. AU - Thompson, C. D. AU - Buck, C. B. AU - Kwak, K. AU - Roden, R. B. PY - 2012 DA - 2012// TI - Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species JO - Virology VL - 433 UR - https://doi.org/10.1016/j.virol.2012.08.035 DO - 10.1016/j.virol.2012.08.035 ID - Handisurya2012 ER - TY - JOUR AU - Jagu, S. AU - Kwak, K. AU - Schiller, J. T. AU - Lowy, D. R. AU - Kleanthous, H. AU - Kalnin, K. PY - 2013 DA - 2013// TI - Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine JO - J. Virol. VL - 87 UR - https://doi.org/10.1128/JVI.03218-12 DO - 10.1128/JVI.03218-12 ID - Jagu2013 ER - TY - JOUR AU - Jagu, S. AU - Kwak, K. AU - Karanam, B. AU - Huh, W. K. AU - Damotharan, V. AU - Chivukula, S. V. PY - 2013 DA - 2013// TI - Optimization of Multimeric Human Papillomavirus L2 Vaccines JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0055538 DO - 10.1371/journal.pone.0055538 ID - Jagu2013 ER - TY - JOUR AU - Berg, M. AU - Gambhira, R. AU - Siracusa, M. AU - Hoiczyk, E. AU - Roden, R. AU - Ketner, G. PY - 2007 DA - 2007// TI - HPV16 L1 capsid protein expressed from viable adenovirus recombinants elicits neutralizing antibody in mice JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2006.06.080 DO - 10.1016/j.vaccine.2006.06.080 ID - Berg2007 ER - TY - JOUR AU - Pastrana, D. V. AU - Buck, C. B. AU - Pang, Y. Y. AU - Thompson, C. D. AU - Castle, P. E. AU - FitzGerald, P. C. PY - 2004 DA - 2004// TI - Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18 JO - Virology VL - 321 UR - https://doi.org/10.1016/j.virol.2003.12.027 DO - 10.1016/j.virol.2003.12.027 ID - Pastrana2004 ER -